# Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

> **NCT00016133** · PHASE1,PHASE2 · COMPLETED · sponsor: **Intracel**

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** BCG vaccine
- **BIOLOGICAL:** autologous tumor cell vaccine
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00016133
- **Lead sponsor:** Intracel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00016133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00016133, "Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00016133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*